Bliss GVS Pharma Ltd
NSE: BLISSGVS BSE: 506197
₹216.26
(-3.03%)
Thu, 12 Mar 2026, 06:36 am
Market Cap23.56B
PE Ratio21.26
Dividend0.45
Health Technology
Pharmaceuticals: Major
24.5KBliss GVS Pharma Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 56.24M | 623.39M | 1.02B | 1.33B | 1.69B | 2.19B | 2.64B | 3.91B | 3.40B | 4.03B | 5.37B | 3.77B | 3.64B | 8.86B | 6.82B | 5.69B | 7.38B | 7.47B | 7.66B | 8.02B |
| Gross profit | 33.63M | 201.53M | 495.34M | 565.78M | 668.02M | 773.54M | 961.60M | 1.62B | 1.29B | 1.75B | 2.27B | 1.35B | 1.24B | 2.13B | 1.68B | 1.45B | 2.44B | 2.33B | 2.49B | 2.33B |
| Operating expenses (excl. COGS) | -16.75M | -136.72M | -141.32M | -210.90M | -204.26M | -238.40M | -307.38M | -625.85M | -735.80M | -869.94M | -945.08M | -671.86M | -430.85M | -716.69M | -623.84M | -620.27M | -1.49B | -1.35B | -1.26B | -1.39B |
| Selling/general/admin expenses, total | -16.42M | -135.37M | -128.61M | -207.72M | -183.39M | -218.72M | -292.03M | -587.75M | -707.83M | -849.19M | -924.99M | -660.27M | -414.92M | -714.14M | -596.80M | -611.83M | -1.48B | -1.34B | -1.26B | -1.39B |
| Research & development | — | — | — | — | — | — | — | — | — | — | -32.09M | -36.81M | -55.22M | -76.12M | -103.69M | -104.89M | -131.01M | -125.63M | -152.30M | -173.68M |
| Selling/general/admin expenses, other | -16.42M | -135.37M | -128.61M | -207.72M | -183.39M | -218.72M | -292.03M | -587.75M | -707.83M | -849.19M | -892.90M | -623.46M | -359.70M | -638.02M | -493.11M | -506.95M | -1.35B | -1.21B | -1.10B | -1.21B |
| Other operating expenses, total | -328.28K | -1.34M | -12.71M | -3.17M | -20.86M | -19.68M | -15.35M | -38.09M | -27.97M | -20.75M | -20.10M | -11.58M | -15.93M | -2.55M | -27.04M | -8.44M | -9.25M | -6.41M | -6.95M | -6.60M |
| Operating income | 16.89M | 64.81M | 354.02M | 354.89M | 463.76M | 535.14M | 654.22M | 998.91M | 556.29M | 881.14M | 1.32B | 675.48M | 812.35M | 1.42B | 1.06B | 830.25M | 950.22M | 978.61M | 1.23B | 934.62M |
| Non-operating income, total | 908.07K | -6.95M | -12.55M | 46.35M | -1.30M | -5.33M | 139.97M | 95.91M | 149.29M | 79.05M | 157.53M | 203.57M | -172.41M | 403.82M | 232.22M | 211.02M | -408.57M | 82.11M | -62.28M | 321.77M |
| Interest expense, net of interest capitalized | -298.26K | -6.66M | -13.83M | -22.62M | -20.44M | -21.47M | -30.64M | -88.50M | -179.82M | -164.12M | -181.99M | -132.48M | -86.02M | -44.15M | -75.69M | -55.14M | -47.42M | -103.64M | -64.23M | -65.48M |
| Interest capitalized | — | — | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 923.62K | 967.29K | 1.28M | 68.97M | 19.14M | 16.15M | 171.81M | 176.70M | 327.68M | 243.10M | 339.41M | 335.91M | -86.39M | 447.45M | 441.37M | 265.97M | -362.63M | 185.75M | 288.51M | 381.04M |
| Non-operating interest income | 337.22K | 874.17K | 782.17K | 422.00K | 6.79M | 5.92M | 22.31M | 38.84M | 40.55M | 55.23M | 69.01M | 61.73M | 46.78M | 68.14M | 66.79M | 95.78M | 88.18M | 75.04M | 117.90M | 151.49M |
| Miscellaneous non-operating expense | 586.40K | 93.12K | 497.74K | 68.55M | 12.35M | 10.23M | 149.50M | 137.86M | 287.13M | 187.87M | 270.40M | 274.18M | -133.17M | 379.31M | 374.59M | 170.18M | -450.82M | 110.71M | 170.61M | 229.55M |
| Unusual income/expense | 282.71K | -1.26M | — | — | — | — | -1.20M | 7.71M | 1.44M | 74.00K | 104.00K | 137.00K | — | 519.00K | -133.46M | 191.00K | 1.49M | 0 | -286.56M | 6.21M |
| Pretax income | 17.79M | 57.86M | 341.47M | 401.24M | 462.46M | 529.81M | 794.19M | 1.09B | 705.58M | 960.19M | 1.48B | 879.05M | 639.94M | 1.82B | 1.29B | 1.04B | 541.65M | 1.06B | 1.17B | 1.26B |
| Taxes | -5.98M | -19.45M | -4.12M | -26.72M | -45.24M | -123.51M | -268.83M | -498.98M | -295.27M | -346.26M | -480.49M | -363.80M | -322.69M | -552.52M | -337.12M | -301.55M | -310.39M | -293.37M | -352.94M | -353.84M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -18.64M | -398.00K | -14.84M | -176.63M | -6.69M | -19.79M | -29.41M | 20.12M | -54.81M | -80.86M | -58.76M | -61.24M | -59.56M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 11.81M | 38.41M | 337.35M | 374.51M | 417.22M | 406.30M | 525.36M | 577.20M | 409.92M | 599.10M | 824.83M | 508.56M | 297.46M | 1.24B | 972.65M | 684.91M | 150.40M | 708.59M | 754.54M | 842.99M |
| Net income | 11.81M | 38.41M | 337.35M | 374.51M | 417.22M | 406.30M | 525.36M | 577.20M | 409.92M | 599.10M | 824.83M | 820.47M | 587.85M | 1.24B | 972.65M | 684.91M | 150.40M | 708.59M | 754.54M | 842.99M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 11.81M | 38.41M | 337.35M | 374.51M | 417.22M | 406.30M | 525.36M | 577.20M | 409.92M | 599.10M | 824.83M | 820.47M | 587.85M | 1.24B | 972.65M | 684.91M | 150.40M | 708.59M | 754.54M | 842.99M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 18.13M | 93.98M | 383.29M | 390.80M | 517.77M | 589.84M | 690.68M | 1.06B | 663.11M | 994.10M | 1.46B | 782.38M | 903.06M | 1.50B | 1.18B | 1.00B | 1.12B | 1.17B | 1.49B | 1.23B |
| EBIT | 16.89M | 64.81M | 354.02M | 354.89M | 463.76M | 535.14M | 654.22M | 998.91M | 556.29M | 881.14M | 1.32B | 675.48M | 812.35M | 1.42B | 1.06B | 830.25M | 950.22M | 978.61M | 1.23B | 934.62M |
| Total operating expenses | -39.36M | -558.58M | -669.94M | -974.67M | -1.22B | -1.65B | -1.99B | -2.91B | -2.84B | -3.15B | -4.04B | -3.10B | -2.83B | -7.45B | -5.76B | -4.86B | -6.43B | -6.50B | -6.43B | -7.08B |
| Prepaid expenses | 17.12M | 18.94M | 105.01M | 39.77M | 98.78M | 116.36M | — | 5.02M | 12.58M | 647.51M | 4.77M | 16.02M | 3.24M | 8.56M | 19.09M | 19.35M | 32.61M | 24.73M | 32.27M | 24.93M |
| Deferred income, current | — | — | — | — | — | — | — | — | 44.06M | 66.52M | 97.26M | 228.47M | 430.21M | 217.06M | 232.22M | 157.91M | 90.08M | 34.70M | 69.24M | 45.70M |
| Capital and operating lease obligations | 0 | 0 | 2.02M | 0 | 493.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.74M | 18.29M | 18.29M | 34.92M | 27.17M | 127.19M | 127.19M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 1.49M | 1.57M | 3.52M | 7.01M | 5.42M | — | 15.76M | 52.22M | 73.33M | 93.59M | 105.99M | 66.38M | 107.41M | 45.36M | 71.26M | 118.03M | 144.83M | 186.61M | 291.86M | 324.11M |
| Deferred income, non-current | — | — | 0 | 0 | — | — | — | — | — | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137.99M | 101.63M | 148.92M | 330.96M | 663.80M | 114.78M | 138.64M | 147.59M | 196.56M | 277.60M | 335.27M | 357.90M | 414.71M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | -4.15M | -7.38M | -7.54M | -18.10M | -96.54M | -78.20M | -82.49M | -48.90M | -86.27M | -61.56M | 0 | -74.49M | -82.37M | -125.00M | -55.49M | -53.27M | -54.37M | -53.95M | -54.49M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800